| Literature DB >> 31378432 |
Stefan Nicolau1, Teerin Liewluck1, Xin-Ming Shen1, Duygu Selcen1, Andrew G Engel1, Margherita Milone2.
Abstract
Mutations in GMPPB cause a wide spectrum of neuromuscular syndromes, including muscular dystrophies and congenital myasthenic syndrome. The mechanisms by which GMPPB mutations impair neuromuscular transmission however remain incompletely understood. We expand here upon a previous report of one such patient presenting with a myopathy-congenital myasthenic syndrome overlap phenotype. Fatigable proximal muscle weakness developed gradually between 13 and 25 years of age, with subsequent stabilization. Low-frequency repetitive nerve stimulation showed a decrement, while a muscle biopsy demonstrated the presence of a centronuclear myopathy. Genetic testing identified a homozygous c.458C > T (p.Thr153Ile) variant in GMPPB. In-vitro microelectrode recordings and ultrastructural studies showed impairment of both pre- and postsynaptic neuromuscular transmission, thus demonstrating the presence of not only postsynaptic, but also presynaptic pathology in GMPPB-related disorders.Entities:
Keywords: Centronuclear myopathy; Congenital myasthenic syndrome; GMPPB; Glycosylation; Neuromuscular junction
Year: 2019 PMID: 31378432 PMCID: PMC6897485 DOI: 10.1016/j.nmd.2019.07.001
Source DB: PubMed Journal: Neuromuscul Disord ISSN: 0960-8966 Impact factor: 4.296